1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. CorMedix Inc.
  6. Consensus
    CRMD   US21900C3088

CORMEDIX INC.

(CRMD)
  Report
Delayed Nasdaq  -  04:00 2022-08-16 pm EDT
4.280 USD   +3.63%
08/12Truist Securities Lowers CorMedix's Price Target to $16 From $27, Maintains Buy Rating
MT
08/11TRANSCRIPT : CorMedix Inc., Q2 2022 Earnings Call, Aug 11, 2022
CI
08/11CORMEDIX INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on CORMEDIX INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) CORMEDIX INC.
Analyst Recommendations on CORMEDIX INC.
08/12Truist Securities Lowers CorMedix's Price Target to $16 From $27, Maintains Buy Rating
MT
08/09JMP Securities Adjusts CorMedix Price Target to $14 From $19, Maintains Market Outperform ..
MT
08/09Needham Adjusts CorMedix's Price Target to $12 from $20, Keeps Buy Rating
MT
2021CORMEDIX : Needham & Co Adjusts CorMedix PT to $29 From $31, Maintains Buy Rating
MT
2021CORMEDIX : B. Riley Lowers CorMedix' Price Target to $13.50 from $25 After FDA Rejects DefenCath Due ..
MT
2021CORMEDIX : Needham Starts CorMedix at Buy With $31 Price Target
MT
2021CORMEDIX : B. Riley Adjusts CorMedix' Price Target to $25 From $11, Keeps Buy Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 4,28 $
Average target price 14,00 $
Spread / Average Target 227%
High Price Target 16,00 $
Spread / Highest target 274%
Low Price Target 12,00 $
Spread / Lowest Target 180%
Consensus detail
Consensus revision (last 18 months)